Find clinical trials for Breast Cancer in Charlotte, NC

in locally advanced unresectable or metastatic triple-negative breast cancer.The main questions it aims to answer are:* to evaluate...

postmenopausal patients with HR-positive, HER2-negative metastatic breast cancer. Pre- and perimenopausal women must receive therap...

in participants with intermediate-risk HR+/HER2- early-stage breast cancer. Based on ctDNA test results, participants will either s...

This is a Phase Ib/II, open-label, multicenter, randomized umbrella study in participants with breast cancer. The study is designed...

the efficacy and safety of palazestrant with ribociclib to letrozole and ribociclib in women and men who have not received prior systemic anti-cancer...

receptor-low/HER2-negative breast cancer....

RATIONALE: Estrogen can cause the growth of breast cancer cells. Hormone therapy using letrozole may fight breast cancer...

This is a Phase 1b open-label, 2-part study in 3 treatment groups. The 3 treatment groups are as follows:Treatment Group 1: Palazestrant (OP-1250) in...

with previously untreated, locally advanced, unresectable or metastatic (Stage IV) programmed death-ligand 1 (PD-L1)-positive triple-negative breast...

to standard endocrine therapy in patients with ER+/HER2 - early breast cancer with intermediate or high risk for disease recurrence...